PLCG2 and Alzheimer disease: Accumulating evidence suggests that the modulation of the TREM2/PLCG2 signaling pathway is a potential therapeutic candidate for AD [16]; however, the role of PLCG2 and the signaling networks associated with PLCG2 in the brain remain unclear.